{"@context":{"@vocab":"https://schema.org/"},"@type":"Drug","@id":"https://api.morvs.ai/drug-product/61755-054#drug","name":"LYNOZYFIC","alternateName":"linvoseltamab-gcpt","identifier":[{"@type":"PropertyValue","propertyID":"FDA National Drug Code (NDC)","value":"61755-054"},{"@type":"PropertyValue","propertyID":"FDA application number","value":"BLA761400"},{"@type":"PropertyValue","propertyID":"UNII","value":"M3CPC50MZS"},{"@type":"PropertyValue","propertyID":"SPL Set ID","value":"e9fd0739-1b3f-4b8b-824a-1f0a902384d3"}],"activeIngredient":"LINVOSELTAMAB","administrationRoute":["INTRAVENOUS"],"dosageForm":"INJECTION, SOLUTION, CONCENTRATE","manufacturer":{"@type":"Organization","name":"Regeneron Pharmaceuticals, Inc."},"drugClass":[],"isAvailableGenerically":false,"legalStatus":"HUMAN PRESCRIPTION DRUG","sameAs":["https://api.morvs.ai/drug-approval/BLA761400","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=e9fd0739-1b3f-4b8b-824a-1f0a902384d3","https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=61755-054"],"isAccessibleForFree":true,"license":"https://creativecommons.org/publicdomain/zero/1.0/","_source":{"data_provider":"AI Analytics","brand_name":"MORVS","brand_url":"https://morvs.ai/","data_provider_url":"https://api.morvs.ai","license":"https://creativecommons.org/publicdomain/zero/1.0/","primary_source":"https://open.fda.gov/apis/drug/ndc/","generated_at":"2026-11-02T19:46:56.883Z"}}